Maximus Inc. (MMS) shares plunged 5.21% in Thursday's trading session after the company reported mixed results for the fiscal first quarter ended December 31, 2024.
While the government health services provider posted adjusted earnings per share of $1.61, exceeding analyst estimates of $1.37, it missed on fourth-quarter EPS expectations, reporting $0.69 versus the consensus estimate of $1.06.
On the positive side, Maximus' revenue for the quarter came in at $1.4 billion, surpassing the $1.29 billion forecasted by analysts. Additionally, the company raised its fiscal 2025 adjusted EPS guidance to a range of $5.90 to $6.20, up from its previous outlook of $5.70 to $6.00.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.